相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interim results from a large multinational extension trial (guardian™2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A
S. R. Lentz et al.
HAEMOPHILIA (2016)
Long-term patterns of safety and efficacy of bleeding prophylaxis with turoctocog alfa (NovoEight®) in previously treated patients with severe haemophilia A: interim results of the guardian™2 extension trial
M. Ozelo et al.
HAEMOPHILIA (2015)
Turoctocog alfa: an evidence-based review of its potential in the treatment of hemophilia A
Hideyuki Takedani et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
Turoctocog alfa (NovoEight®) - from design to clinical proof of concept
Mirella Ezban et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2014)
Guidelines for the management of hemophilia
A. Srivastava et al.
HAEMOPHILIA (2013)
Results from a large multinational clinical trial (guardian™3) using prophylactic treatment with turoctocog alfa in paediatric patients with severe haemophilia A: safety, efficacy and pharmacokinetics
R. Kulkarni et al.
HAEMOPHILIA (2013)
Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy
S. R. Lentz et al.
HAEMOPHILIA (2013)
分享论文
